These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18036566)

  • 41. Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling.
    Da'adoosh B; Marcus D; Rayan A; King F; Che J; Goldblum A
    Sci Rep; 2019 Jan; 9(1):1106. PubMed ID: 30705343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PPAR dual agonists: are they opening Pandora's Box?
    Balakumar P; Rose M; Ganti SS; Krishan P; Singh M
    Pharmacol Res; 2007 Aug; 56(2):91-8. PubMed ID: 17428674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta.
    Yan ZC; Liu DY; Zhang LL; Shen CY; Ma QL; Cao TB; Wang LJ; Nie H; Zidek W; Tepel M; Zhu ZM
    Biochem Biophys Res Commun; 2007 Mar; 354(2):427-33. PubMed ID: 17223076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PPAR delta agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle.
    Lim HJ; Lee S; Park JH; Lee KS; Choi HE; Chung KS; Lee HH; Park HY
    Atherosclerosis; 2009 Feb; 202(2):446-54. PubMed ID: 18585719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages.
    Luo Y; Tanigawa K; Kawashima A; Ishido Y; Ishii N; Suzuki K
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008850. PubMed ID: 33075048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
    Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
    Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lysophosphatidylcholines activate PPARδ and protect human skeletal muscle cells from lipotoxicity.
    Klingler C; Zhao X; Adhikary T; Li J; Xu G; Häring HU; Schleicher E; Lehmann R; Weigert C
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1980-1992. PubMed ID: 27697477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural compounds regulate energy metabolism by the modulating the activity of lipid-sensing nuclear receptors.
    Goto T; Kim YI; Takahashi N; Kawada T
    Mol Nutr Food Res; 2013 Jan; 57(1):20-33. PubMed ID: 23180608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta.
    Oishi Y; Manabe I; Tobe K; Ohsugi M; Kubota T; Fujiu K; Maemura K; Kubota N; Kadowaki T; Nagai R
    Nat Med; 2008 Jun; 14(6):656-66. PubMed ID: 18500350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes.
    Serrano-Marco L; Chacón MR; Maymó-Masip E; Barroso E; Salvadó L; Wabitsch M; Garrido-Sánchez L; Tinahones FJ; Palomer X; Vendrell J; Vázquez-Carrera M
    Biochim Biophys Acta; 2012 Sep; 1821(9):1177-85. PubMed ID: 22683888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction between platelets and endothelial progenitor cells via LPA-Edg-2 axis is augmented by PPAR-δ activation.
    Han JK; Kim BK; Won JY; Shin Y; Choi SB; Hwang I; Kang J; Lee HJ; Koh SJ; Lee J; Hur J; Cho HJ; Chae IH; Oh BH; Park YB; Kim HS
    J Mol Cell Cardiol; 2016 Aug; 97():266-77. PubMed ID: 27266389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
    Alvarez-Guardia D; Palomer X; Coll T; Serrano L; Rodríguez-Calvo R; Davidson MM; Merlos M; El Kochairi I; Michalik L; Wahli W; Vázquez-Carrera M
    Biochim Biophys Acta; 2011 Feb; 1811(2):59-67. PubMed ID: 21070867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of PPAR-delta agonist on the expression of visfatin, adiponectin, and resistin in rat adipose tissue and 3T3-L1 adipocytes.
    Choi KC; Lee SY; Yoo HJ; Ryu OH; Lee KW; Kim SM; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2007 May; 357(1):62-7. PubMed ID: 17418807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice.
    Jung TW; Lee SH; Kim HC; Bang JS; Abd El-Aty AM; Hacımüftüoğlu A; Shin YK; Jeong JH
    Exp Mol Med; 2018 Sep; 50(9):1-11. PubMed ID: 30213948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipids, lipoproteins, and peroxisome proliferator activated receptor-delta.
    Sprecher DL
    Am J Cardiol; 2007 Dec; 100(11 A):n20-4. PubMed ID: 18047848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Critical role of peroxisome proliferator activated receptor-δ on body fat reduction in C57BL/6J and human apolipoprotein E2 transgenic mice fed delipidated soybean.
    Lee JH; Jun HJ; Jia Y; Kim W; Choi SG; Lee SJ
    J Agric Food Chem; 2011 Nov; 59(21):11872-81. PubMed ID: 21894990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease.
    Vázquez-Carrera M
    Trends Endocrinol Metab; 2016 May; 27(5):319-334. PubMed ID: 27005447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.
    Sahebkar A; Chew GT; Watts GF
    Expert Opin Pharmacother; 2014 Mar; 15(4):493-503. PubMed ID: 24428677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prenatal fat exposure and hypothalamic PPAR β/δ: Possible relationship to increased neurogenesis of orexigenic peptide neurons.
    Chang GQ; Karatayev O; Lukatskaya O; Leibowitz SF
    Peptides; 2016 May; 79():16-26. PubMed ID: 27002387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostacyclin synthase gene transfer inhibits neointimal formation by suppressing PPAR delta expression.
    Imai H; Numaguchi Y; Ishii M; Kubota R; Yokouchi K; Ogawa Y; Kondo T; Okumura K; Murohara T
    Atherosclerosis; 2007 Dec; 195(2):322-32. PubMed ID: 17303142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.